purpos
studi
elucid
possibl
presenc
oxid
stress
cat
natur
affect
felin
infecti
periton
fip
investig
two
antioxid
biomark
serum
total
antioxid
capac
tac
measur
spectrophotometr
assay
use
three
differ
substrat
pnitrophenyl
acet
pna
phenyl
acet
pa
butyrolacton
tbbl
order
evalu
possibl
differ
pa
tbbl
assay
assay
tac
valid
provid
accept
precis
linear
although
pa
tac
assay
show
limit
detect
higher
valu
found
cat
fip
cat
fip
inflammatori
condit
show
lower
valu
compar
group
healthi
cat
three
assay
use
cat
fip
show
signific
decreas
tac
concentr
studi
demonstr
exist
oxid
stress
cat
fip
oxid
stress
defin
imbal
oxid
antioxid
system
advantag
toward
oxid
system
suresh
et
al
situat
organ
unabl
detoxifi
reactiv
oxygen
speci
accumul
produc
harm
effect
function
structur
integr
biolog
tissu
yilmaz
cat
seem
suscept
oxid
stress
damag
probabl
influenc
particular
spleen
structur
speci
christoph
et
al
harvey
kaneko
situat
oxid
stress
demonstr
variou
diseas
speci
diabet
mellitu
webb
falkowski
chronic
renal
failur
keegan
webb
felin
immunodefici
viru
fiv
infect
webb
et
al
howev
author
knowledg
studi
oxid
stress
felin
infecti
periton
fip
viral
diseas
result
felin
coronaviru
fcov
infect
inflamm
play
major
role
fip
infect
sinc
major
inflammatori
respons
present
cours
fip
involv
pathogenesi
produc
fibrin
seros
accumul
highli
proteinac
fluid
within
bodi
caviti
dissemin
pyogranulomat
format
hypergammaglobulinemia
develop
immun
complex
gunnmoor
et
al
pedersen
increas
acut
phase
protein
app
marker
inflamm
glycoprotein
serum
amyloid
use
diagnost
aid
diseas
know
relat
inflamm
oxid
stress
montorfano
et
al
could
postul
oxid
stress
could
present
cat
affect
fip
sever
enzym
nonenzymat
molecul
includ
within
antioxid
system
delmasbeauvieux
et
al
paraoxonas
serum
enzym
protect
role
oxid
jame
human
reduct
activ
report
sever
patholog
condit
includ
bacteri
viral
infect
farid
horii
addit
associ
inflamm
consid
neg
acut
phase
protein
sever
speci
feingold
et
al
report
reduc
hepat
synthesi
enzym
hamster
acut
phase
respons
decreas
also
describ
cattl
bionaz
et
al
laboratori
anim
francopon
et
al
human
novak
et
al
hors
turk
et
al
dog
tvarijonaviciut
et
al
tvarijonaviciut
et
al
owe
wide
spectrum
speci
reduc
inflamm
studi
molecul
also
cat
may
import
lacton
consid
natur
substrat
billeck
et
al
artifici
substrat
also
use
measur
enzym
paraoxon
phenyl
acet
pa
pnitrophenyl
acet
pna
ceron
et
al
howev
use
paraoxon
substrat
would
optim
due
toxic
camp
et
al
possibl
analyz
contamin
mogarekar
chawhan
diverg
diagnost
perform
differ
substrat
describ
certain
diseas
dantoin
et
al
keskin
et
al
therefor
compar
studi
variou
substrat
use
measur
would
recommend
enzym
evalu
new
diseas
serum
total
antioxid
capac
tac
consid
cumul
effect
antioxid
present
blood
nagi
et
al
provid
integr
index
oxid
statu
ghiselli
et
al
wide
use
colorimetr
method
base
oxid
colorless
molecul
abt
bluegreen
abt
erel
decreas
tac
report
human
patient
hiv
infect
neg
correl
lipid
peroxid
suggest
presenc
oxid
stress
individu
suresh
et
al
hypothes
oxid
stress
could
present
cat
affect
fip
probabl
influenc
major
inflammatori
reaction
associ
diseas
therefor
chang
serum
oxid
biomark
may
present
test
hypothesi
serum
activ
tac
group
cat
natur
affect
fip
measur
compar
group
healthi
cat
cat
inflammatori
diseas
activ
measur
use
three
differ
substrat
pna
pa
butyrolacton
tbbl
evalu
possibl
differ
valu
fip
depend
substrat
assay
measur
use
pa
tbbl
assay
tac
determin
valid
use
cat
retrospect
studi
serum
sampl
cat
select
author
veterinari
hospit
databas
serum
sampl
correspond
diagnos
made
base
physic
examin
hematolog
biochemistri
evalu
urinalys
radiographi
ultrasonographi
cytolog
serolog
immunohistochemistri
depend
clinic
case
base
result
differ
diagnost
approach
serum
sampl
select
separ
group
serum
clinic
healthi
cat
present
routin
health
screen
examin
control
group
cat
histori
ill
clinic
sign
physic
examin
serolog
neg
fcov
infect
use
indirect
fluoresc
antibodi
vmrd
fiv
felin
leukaemia
viru
felv
infect
use
commerci
avail
elisa
test
virachek
synbiot
serolog
consid
posit
titer
case
felv
fiv
test
titer
case
fcov
test
cat
show
clinic
sign
compat
fip
year
sampl
collect
second
group
consist
serum
cat
natur
infect
fcov
present
clinic
sign
consist
fip
cat
neg
serolog
fiv
felv
hematolog
chang
includ
low
pack
cell
volum
cat
neutrophilia
cat
lymphopenia
cat
fip
diagnosi
confirm
cat
necropsi
histolog
immunohistochemistri
licitra
et
al
fourteen
cat
effus
fip
cat
noneffus
dri
form
third
group
consist
serum
cat
inflammatori
diseas
group
compris
cat
serolog
neg
fcov
felv
fiv
infect
high
serum
amyloid
saa
concentr
median
interquartil
rang
consist
inflammatori
diseas
diagnos
group
includ
felin
lower
urinari
tract
diseas
bone
fractur
cholangiohepat
n
chronic
renal
insuffici
asept
pneumonia
gastroenter
cranial
trauma
dehisc
surgic
stitch
chronic
interstiti
nephriti
pyometra
n
one
cat
cholangiohepat
cat
chronic
renal
insuffici
cat
chronic
interstiti
nephriti
die
period
less
year
collect
sampl
post
mortem
examin
rule
presenc
fip
cat
surviv
present
sign
compat
fip
year
collect
sampl
serum
sampl
kept
analys
tac
saa
studi
approv
ethic
committe
univers
murcia
spain
activ
measur
follow
previous
describ
method
tvarijonaviciut
et
al
three
hundr
microlit
work
reagent
consist
mm
tri
tri
hydroxymethyl
aminomethan
sigmaaldrich
ph
mm
calcium
chlorid
dihydr
sigmaaldrich
ad
togeth
serum
sampl
incub
period
start
reagent
consist
mm
pna
sigmaaldrich
water
ad
rate
format
pnitrophenol
determin
nm
autom
chemistri
analyz
olympu
nonenzymat
hydrolysi
pna
base
hydrolysi
rate
absenc
serum
subtract
total
hydrolysi
rate
activ
express
uml
base
molar
absorpt
pnitrophenol
nm
method
previous
valid
cat
tvarijonaviciut
et
al
method
activ
analyz
measur
hydrolysi
pa
phenol
describ
elsewher
van
himbergen
et
al
assay
perform
micropl
sampl
buffer
consist
mm
tri
mm
ph
serum
sampl
dilut
sampl
buffer
ratio
dilut
sampl
ad
well
freshli
made
substrat
reagent
contain
mm
pa
sigmaaldrich
sampl
buffer
ad
reaction
monitor
min
nm
micropl
reader
powerwav
xs
biotek
instrument
nonenzymat
hydrolysi
pa
base
hydrolysi
rate
absenc
serum
subtract
total
hydrolysi
rate
activ
express
uml
serum
molar
extinct
coeffici
use
calcul
rate
hydrolysi
method
involv
use
chromogen
lacton
structur
resembl
propos
natur
lipolacton
substrat
assay
perform
micropl
sampl
buffer
consist
mm
tri
mm
ph
method
compris
four
pippet
step
chromophor
solut
contain
mm
acid
sigmaaldrich
co
dimethyl
sulfoxid
sigmaaldrich
co
ad
well
follow
acetonitril
mulrisolv
hplc
grade
ac
sharlau
chemi
sa
sentmenat
spain
solut
sampl
buffer
third
step
dilut
serum
sampl
ratio
sampl
buffer
ad
final
freshli
made
substrat
contain
mm
tbbl
provid
dr
khersonski
weizmann
institut
scienc
israel
sampl
buffer
ad
two
minut
tbbl
addit
reaction
monitor
nm
autom
micropl
reader
powerwav
xs
nonenzymat
hydrolysi
tbbl
base
hydrolysi
rate
absenc
serum
subtract
total
hydrolysi
rate
activ
express
uml
serum
unit
equal
mmol
tbbl
hydrolyzedmin
molar
extinct
coeffici
use
calcul
rate
hydrolysi
method
describ
erel
valid
use
cat
method
bluegreen
color
oxid
acid
abt
reduc
colorless
molecul
chang
color
spectrophotometr
monitor
reagent
consist
acet
buffer
solut
ph
includ
sigmaaldrich
glacial
acet
acid
sigmaaldrich
reagent
consist
acet
buffer
ph
contain
mm
glacial
acet
acid
hydrogen
peroxid
panreac
sa
mm
abt
diammonium
salt
sigmaaldrich
two
hundr
fifti
microlit
reagent
serum
sampl
mix
incub
reagent
ad
chang
absorb
monitor
nm
method
adapt
autom
analyz
olympu
presenc
inflamm
assess
measur
serum
acut
phase
protein
saa
concentr
saa
measur
use
commerci
avail
immunoturbidimetr
method
saatia
lzsaa
eiken
chemic
co
tokyo
japan
adapt
autom
analyz
olympu
method
previous
valid
felin
specimen
kajikawa
et
al
sinc
method
previous
valid
felin
specimen
analyt
valid
perform
precis
determin
calcul
intraassay
coeffici
variat
cv
two
pool
sera
differ
tac
concentr
pool
low
activ
low
tac
concentr
perform
mix
volum
serum
diseas
anim
randomli
chosen
pool
expect
high
activ
high
tac
concentr
prepar
mix
sera
healthi
anim
pool
analyz
six
time
singl
assay
run
interassay
cv
determin
analyz
pool
six
separ
run
differ
day
sera
frozen
aliquot
vial
need
run
use
avoid
possibl
chang
due
repetit
thaw
freez
linear
evalu
use
method
linear
dilut
pool
serum
high
valu
tac
dilut
twofold
basi
sampl
buffer
assay
triplic
result
compar
expect
linear
regress
analysi
limit
detect
assay
lowest
concentr
analyt
could
distinguish
specimen
valu
zero
calcul
mean
plu
standard
deviat
data
gener
replic
determin
zero
standard
sampl
buffer
routin
descript
statist
paramet
calcul
routin
descript
statist
procedur
kolmogorovsmirnov
test
perform
assess
normal
data
obtain
healthi
diseas
cat
data
give
nonparametr
distribut
logtransform
prior
statist
analysi
oneway
analysi
varianc
tukey
posthoc
test
use
determin
valu
obtain
healthi
diseas
anim
statist
differ
pearson
correl
coeffici
calcul
assess
correl
tac
saa
signific
level
use
case
p
statist
analys
calcul
use
spreadsheet
excel
microsoft
graph
pad
softwar
inc
graphpad
prism
version
window
graph
pad
softwar
intraand
interassay
cv
obtain
measur
pa
tbbl
tac
analysi
shown
tabl
intraassay
cv
lower
case
interassay
cv
lower
pa
tbbl
tac
respect
coeffici
linear
regress
higher
observ
pool
serum
dilut
analyz
valid
method
fig
calcul
limit
detect
u
ml
uml
mmoll
pa
tbbl
tac
respect
tabl
show
tac
saa
valu
cat
includ
studi
significantli
lower
activ
observ
substrat
cat
fip
inflammatori
di
tabl
mean
standard
deviat
sd
coeffici
variat
cv
obtain
paraoxonas
total
antioxid
capac
pool
cat
sera
interassay
eas
compar
healthi
cat
tac
significantli
lower
cat
fip
compar
healthi
cat
cat
inflammatori
condit
saa
concentr
significantli
higher
cat
fip
inflammatori
diseas
healthi
anim
saa
concentr
significantli
higher
cat
fip
cat
inflammatori
diseas
tabl
valu
differ
analyt
cat
effus
noneffus
form
appear
cat
effus
form
show
significantli
lower
valu
tac
higher
valu
saa
compar
cat
noneffus
form
signific
correl
observ
measur
differ
substrat
tac
assay
tac
measur
show
signific
weak
neg
correl
saa
concentr
tabl
report
assay
activ
three
differ
substrat
pna
pa
tbbl
tac
use
assay
use
pa
tbbl
assay
tac
determin
first
valid
felin
sampl
assay
method
use
pa
tbbl
show
precis
result
abl
measur
linear
manner
similar
result
previous
report
dog
tvarijonaviciut
et
al
although
one
cat
fip
show
valu
limit
detect
pa
use
tac
assay
precis
linear
valu
higher
limit
detect
assay
howev
cat
fip
one
cat
inflammatori
condit
show
tac
valu
calcul
limit
detect
exist
valu
lower
limit
detect
consid
limit
assay
use
pa
substrat
tac
assay
especi
case
fip
inflammatori
condit
low
valu
expect
author
knowledg
first
report
measur
tac
cat
fip
inflammatori
condit
signific
decreas
activ
three
substrat
observ
group
diseas
cat
report
found
cat
studi
possibl
oxid
stress
associ
obes
tvarijonaviciut
et
al
sever
reason
could
explain
decreas
activ
cat
fip
one
reason
oxid
stress
corrobor
low
tac
concentr
cat
oxid
stress
known
involv
pathogenesi
human
virus
exampl
hepat
c
viru
infect
associ
accumul
reactiv
oxygen
speci
reduc
glutathion
activ
paracha
et
al
hiv
infect
decreas
activ
parra
et
al
parra
et
al
tac
suresh
et
al
presenc
inflamm
increas
inflammatori
cytokin
appear
cat
fip
regan
et
al
could
also
explain
decreas
activ
sinc
consid
part
innat
immun
system
chun
et
al
neg
acut
phase
protein
decreas
inflamm
novak
et
al
tvarijonaviciut
et
al
seen
studi
group
cat
inflammatori
condit
inflamm
result
loss
hdlcholesterol
molecul
replac
saa
kappel
et
al
could
explain
increas
saa
decreas
demonstr
cat
fip
studi
indic
pronounc
inflammatori
respons
signific
although
weak
neg
correl
observ
saa
saa
analysi
perform
order
assess
presenc
inflammatori
respons
cat
use
studi
although
agp
report
app
choic
cat
fip
chose
saa
sinc
autom
method
measur
easier
agp
determin
current
made
lab
radial
immun
diffus
techniqu
besid
demonstr
saa
show
similar
respons
fip
cat
agp
giordano
et
al
although
three
substrat
use
assay
provid
similar
result
decreas
cat
fip
technic
point
view
pna
could
consid
ideal
substrat
compar
pa
less
toxic
lower
limit
quantif
tvarijonaviciut
et
al
addit
pna
assay
also
autom
therebi
allow
higher
specimen
throughput
avoid
pipet
error
result
higher
precis
tbbl
exceed
recommend
limit
interassay
measur
guidanc
industri
bioanalyt
method
valid
us
studi
perform
dog
higher
signific
differ
dog
oxid
damag
healthi
dog
found
pna
compar
pa
tbbl
tvarijonaviciut
et
al
anoth
import
limit
tbbl
use
substrat
commerci
avail
fip
cat
weteffus
form
show
lower
valu
tac
indic
higher
oxid
stress
compar
cat
dri
form
could
relat
poorer
outcom
fip
cat
effus
form
compar
dri
form
pedersen
although
studi
made
elucid
oxid
marker
could
help
establish
prognost
fip
case
knowledg
pathogenesi
fip
remain
basic
level
pedersen
studi
influenc
oxid
stress
physiopatholog
fip
undertaken
howev
viral
infecti
hiv
chang
variou
antioxid
defens
may
also
associ
progress
diseas
treiting
et
al
one
point
discuss
could
consid
limit
paper
high
cutoff
test
use
consid
cat
fcov
seroposit
chosen
coronaviru
antibodi
titer
increasingli
suggest
fip
higher
titer
pedersen
could
argu
use
lower
cutoff
ie
would
allow
detect
fcov
seroposit
cat
howev
consid
coronaviru
antibodi
titer
mislead
rang
pedersen
paper
report
first
time
decreas
two
antioxid
biomark
tac
cat
fip
compar
healthi
anim
indic
situat
oxid
stress
appear
fip
possibl
associ
inflammatori
respons
occur
diseas
research
perform
explor
possibl
practic
applic
monitor
oxid
stress
could
diseas
well
possibl
antioxid
therapeut
prevent
potenti
